A detailed history of Cape Investment Advisory, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 117 shares of VCEL stock, worth $6,632. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117
Previous 92 27.17%
Holding current value
$6,632
Previous $4.22 Million 17.1%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.25 - $53.56 $1,056 - $1,339
25 Added 27.17%
117 $4.94 Million
Q2 2024

Aug 14, 2024

BUY
$41.71 - $52.9 $2,919 - $3,703
70 Added 318.18%
92 $4.22 Million
Q1 2024

Jun 21, 2024

BUY
$32.52 - $52.33 $715 - $1,151
22 New
22 $1.14 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Cape Investment Advisory, Inc. Portfolio

Follow Cape Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cape Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cape Investment Advisory, Inc. with notifications on news.